Cargando…
Aberrant Loss of Surface CD3 and TCRγδ Expression in Relapsed Hepatosplenic T-cell Lymphoma
Autores principales: | Lee, Beomki, Lim, Dae Jin, Heo, Won Young, Yoon, Sang Eun, Kim, Hyun-Young, Kim, Hee-Jin, Kim, Sun-Hee, Cho, Duck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203428/ https://www.ncbi.nlm.nih.gov/pubmed/34108288 http://dx.doi.org/10.3343/alm.2021.41.6.598 |
Ejemplares similares
-
Profuse telangiectasias in an immunocompetent patient misleading presentation revealing a hepatosplenic‐Tγδ‐cell lymphoma
por: Diarra, Ava, et al.
Publicado: (2022) -
Marked Increase of Circulating Double-Negative γδ T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma
por: Shin, Sang-Yong, et al.
Publicado: (2016) -
Selective activation of TCR-γδ(+ )cells in endemic Burkitt's lymphoma
por: Futagbi, Godfred, et al.
Publicado: (2007) -
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression
por: Song, Wei, et al.
Publicado: (2022) -
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma
por: Xu, Xueer, et al.
Publicado: (2023)